Novartis’ continuing search for new ways to take drugs into the brain has resulted in a $1.7 billion deal with SciNeuro ...
Morning Overview on MSN
SciNeuro, Novartis strike $1.7B Alzheimer’s drug megadeal
Novartis has agreed to pay up to $1.7 billion to license an experimental Alzheimer’s therapy from China-based SciNeuro, a ...
Manifold Biotechnologies Inc. has signed a strategic research collaboration and license agreement with F. Hoffmann-La Roche Ltd. to develop next-generation brain shuttles for neurological diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback